Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Completed · Phase 3

Conditions studied: ADHD

In brief

The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.

Key facts

Study ID

NCT00141050

Run by

Novartis

People needed

90

Starts

2005-05-01

Expected to finish

2005-07-01

Last updated by the study team

2007-12-21

Who can join

Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV diagnosis of ADHD
• Males and females aged 6-12

You may not qualify if…

• Inability to understand or follow instructions
• Is pregnant
• Diagnosis of tic disorder
• History of seizure disorder

Where it is running

• Bayou City Research — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.